Hansa Biopharma AB (HNSBF)
2.90
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Hansa Biopharma Profit Margin (Quarterly) : -567.9% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -567.9% |
| December 31, 2025 | -217.2% |
| September 30, 2025 | -481.3% |
| June 30, 2025 | -364.2% |
| March 31, 2025 | -58.55% |
| December 31, 2024 | -854.8% |
| September 30, 2024 | -213.3% |
| June 30, 2024 | -605.6% |
| March 31, 2024 | -390.5% |
| December 31, 2023 | -246.9% |
| September 30, 2023 | -1.10K% |
| June 30, 2023 | -685.3% |
| March 31, 2023 | -849.0% |
| December 31, 2022 | -478.2% |
| September 30, 2022 | -229.5% |
| June 30, 2022 | -644.3% |
| March 31, 2022 | -457.2% |
| December 31, 2021 | -1.06K% |
| September 30, 2021 | -3.00K% |
| June 30, 2021 | -2.92K% |
| March 31, 2021 | -1.16K% |
| December 31, 2020 | -2.76K% |
| September 30, 2020 | -16.07K% |
| Date | Value |
|---|---|
| June 30, 2020 | -15.92K% |
| March 31, 2020 | -10.55K% |
| December 31, 2019 | -9.21K% |
| September 30, 2019 | -14.46K% |
| June 30, 2019 | -13.91K% |
| March 31, 2019 | -7.91K% |
| December 31, 2018 | -5.86K% |
| September 30, 2018 | -12.70K% |
| June 30, 2018 | -6.53K% |
| March 31, 2018 | -7.91K% |
| December 31, 2017 | -4.83K% |
| September 30, 2017 | -5.54K% |
| June 30, 2017 | -6.51K% |
| March 31, 2017 | -4.25K% |
| December 31, 2016 | -6.18K% |
| September 30, 2016 | -2.97K% |
| June 30, 2016 | -5.66K% |
| March 31, 2016 | -3.40K% |
| December 31, 2015 | -1.56K% |
| September 30, 2015 | -2.64K% |
| June 30, 2015 | -4.25K% |
| March 31, 2015 | -278.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioArctic AB | 48.54% |
| Swedish Orphan Biovitrum AB | 18.35% |
| Diamyd Medical AB | -63.69K% |
| BONESUPPORT HOLDING AB | 16.47% |
| BioInvent International AB | -888.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -75.34% |
| Return on Invested Capital | -118.0% |
| Gross Profit Margin (Quarterly) | 60.14% |
| Operating Margin (Quarterly) | -411.1% |
| Return on Net Operating Assets | -189.8% |